Mezzion Pharma Co Ltd (140410)

Currency in KRW
36,600
-250(-0.68%)
Delayed Data·
140410 Scorecard
Full Analysis
Net income is expected to grow this year
140410 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
36,20036,900
52 wk Range
25,45043,300
Key Statistics
Bid/Ask
36,550.00 / 36,600.00
Prev. Close
36,850
Open
36,900
Day's Range
36,200-36,900
52 wk Range
25,450-43,300
Volume
15.3K
Average Volume (3m)
89.73K
1-Year Change
10.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
140410 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Mezzion Pharma Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Mezzion Pharma Co Ltd Company Profile

Mezzion Pharma Co.,Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company developing JURVIGO, which is in Phase 3 clinical trial for treatment option to improve the physiology and exercise capacity of Fontan patients 12 years and older. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.

Employees
19

Compare 140410 to Peers and Sector

Metrics to compare
140410
Peers
Sector
Relationship
P/E Ratio
−48.4x5.2x−0.5x
PEG Ratio
0.410.040.00
Price/Book
25.6x0.9x2.6x
Price / LTM Sales
131.6x0.8x3.3x
Upside (Analyst Target)
-68.7%43.3%
Fair Value Upside
Unlock12.8%6.9%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-110.41 / --
Revenue / Forecast
1.95B / --
EPS Revisions
Last 90 days

140410 Income Statement

People Also Watch

42,100
008930
-2.88%
173,300
068270
-0.46%
27,650
096530
-7.99%
59,300
214150
-0.34%
13,290
336570
+4.32%

FAQ

What Stock Exchange Does Mezzion Pharma Trade On?

Mezzion Pharma is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Mezzion Pharma?

The stock symbol for Mezzion Pharma is "140410."

What Is the Mezzion Pharma Market Cap?

As of today, Mezzion Pharma market cap is 1.11T.

What Is Mezzion Pharma's Earnings Per Share (TTM)?

The Mezzion Pharma EPS (TTM) is -764.29.

From a Technical Analysis Perspective, Is 140410 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mezzion Pharma Stock Split?

Mezzion Pharma has split 1 times.

How Many Employees Does Mezzion Pharma Have?

Mezzion Pharma has 19 employees.

What is the current trading status of Mezzion Pharma (140410)?

As of 11 Aug 2025, Mezzion Pharma (140410) is trading at a price of 36,600.00, with a previous close of 36,850.00. The stock has fluctuated within a day range of 36,200.00 to 36,900.00, while its 52-week range spans from 25,450.00 to 43,300.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.